SB
Insider
Stephen F. Betz
Chief Scientific OfficerStephen F. Betz (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $397K of CRNX (10,612 sh across 2 lots, as filed), executed Mar 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$397K
shares × price, as filed
Last traded
Mar 16
Filed Mar 18
Median ADV $326.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CRNXRecent filings
CRNXSALE
Crinetics Pharmaceuticals, Inc.
View filing →
$397K10,612 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $3.1M
97,483 sh × $32.23
Exec Jun 12 2025
Filed Jun 16 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $187K
5,479 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET